Biodefense Research Section, Vaccine Research Center, National Institutes of Health, Vaccine Research Center, 40 Convent Drive, Bldg. 40/2509, Bethesda, MD 20892, USA.
J Virol. 2011 Mar;85(6):2512-23. doi: 10.1128/JVI.01160-10. Epub 2011 Jan 12.
Cellular RNA interference (RNAi) provides a natural response against viral infection, but some viruses have evolved mechanisms to antagonize this form of antiviral immunity. To determine whether Ebolavirus (EBOV) counters RNAi by encoding suppressors of RNA silencing (SRSs), we screened all EBOV proteins using an RNAi assay initiated by exogenously delivered small interfering RNAs (siRNAs) against either an EBOV or a reporter gene. In addition to viral protein 35 (VP35), we found that VP30 and VP40 independently act as SRSs. Here, we present the molecular mechanisms of VP30 and VP35. VP30 interacts with Dicer independently of siRNA and with one Dicer partner, TRBP, only in the presence of siRNA. VP35 directly interacts with Dicer partners TRBP and PACT in an siRNA-independent fashion and in the absence of effects on interferon (IFN). Taken together, our findings elucidate a new mechanism of RNAi suppression that extends beyond the role of SRSs in double-stranded RNA (dsRNA) binding and IFN antagonism. The presence of three suppressors highlights the relevance of host RNAi-dependent antiviral immunity in EBOV infection and illustrates the importance of RNAi in shaping the evolution of RNA viruses.
细胞 RNA 干扰 (RNAi) 提供了一种针对病毒感染的自然反应,但有些病毒已经进化出了拮抗这种抗病毒免疫的机制。为了确定埃博拉病毒 (EBOV) 是否通过编码 RNA 沉默抑制因子 (SRSs) 来对抗 RNAi,我们使用外源性小干扰 RNA (siRNA) 引发的 RNAi 测定筛选了所有 EBOV 蛋白,这些 siRNA 针对 EBOV 或报告基因。除了病毒蛋白 35 (VP35) 外,我们还发现 VP30 和 VP40 独立作为 SRSs 发挥作用。在这里,我们介绍了 VP30 和 VP35 的分子机制。VP30 独立于 siRNA 与 Dicer 相互作用,并且仅在存在 siRNA 的情况下与 Dicer 伴侣 TRBP 相互作用。VP35 以不依赖 siRNA 的方式与 Dicer 伴侣 TRBP 和 PACT 直接相互作用,并且对干扰素 (IFN) 没有影响。总之,我们的发现阐明了 RNAi 抑制的新机制,该机制超越了 SRSs 在双链 RNA (dsRNA) 结合和 IFN 拮抗中的作用。三种抑制剂的存在突出了宿主依赖 RNAi 的抗病毒免疫在 EBOV 感染中的相关性,并说明了 RNAi 在塑造 RNA 病毒进化中的重要性。